George Grunberger MD FACP, MACE
Diabetes, Lipid Metabolism, Obesity
Clinical Professor, Internal Medicine and Molecular Medicine & Genetics, Wayne State University School of Medicine Professor, Internal Medicine, Oakland University William Beaumont School of Medicine Visiting Professor, First Faculty of Medicine, Charles University, Prague (Czech Republic)
Join to View Full Profile
43494 Woodward AveSte 208Bloomfield Hills, MI 48302
Phone+1 248-335-7740
Fax+1 248-338-7979
Dr. Grunberger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- George Grunberger, MD, is an endocrinology specialist based in Bloomfield Hills, MI with sub-specialties in diabetes, lipid metabolism, and obesity. His educational background includes a BS in Biochemistry from Columbia College, MD from New York University School of Medicine, and a Fellowship in Endocrinology, Diabetes, and Metabolism from NIH Clinical Center. He has held several distinguished positions, including Chairman of Grunberger Diabetes Medical Center and Tenured Professor at Wayne State University School of Medicine. He is experienced in managing conditions such as metabolic syndrome, diabetic neuropathy, and diabetes. Dr. Grunberger has contributed to multiple publications and has been involved in over 100 clinical trials. His work has received recognition with honors from the American College of Endocrinology and the American College of Physicians.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1983
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1977 - 1980
New York University School of MedicineClass of 1977
Columbia CollegeB.S., Biochemistry, 1969 - 1973
Certifications & Licensure
MI State Medical License 1986 - 2026
MD State Medical License 1980 - 1986
OH State Medical License 1978 - 1979
American Board of Internal Medicine Internal Medicine
National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Master American College of Endocrinology, 2020
- CMS Meaningful Use Stage Stage 1 Certification Paragon® with McKesson Quality eMeasures™, McKesson, 2013-2017
- CMS Meaningful Use Stage Stage 2 Certification Practice Fusion EHR, Practice Fusion, 2013-2017
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting Start of enrollment: 2012 Jan 01
- Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Publications & Presentations
PubMed
- Evaluating pain and neurological function with high frequency 10 kHz spinal cord stimulation in the treatment of painful diabetic neuropathy: design of a multicentre, ...Rodica Pop-Busui, Erika A Petersen, Brian L Levy, Solomon Tesfaye, David G Armstrong
BMJ Open. 2025-11-27 - Switch of Open-Source Automated Insulin Delivery (AID) System-AndroidAPS to Commercially Available AID Systems in Type 1 Diabetes: The Extension of the CODIAC Study.Quoc Dat Do, Lucie Radovnická, Aneta Hásková, Judita Konečná, Eva Horová
Diabetes Technology & Therapeutics. 2025-11-01 - 1 citationsAddressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies.Davida F Kruger, Christopher G Parkin, Irl B Hirsch, Grazia Aleppo, Janet B McGill
Journal of Diabetes Science and Technology. 2025-04-10
Lectures
- New Strategies for Obesity Management: Risk Stratification & Long-term Weight ControlAmerican Association of Clinical Endocrinologists (AACE), Dearborn, Michigan - 10/5/2013
- New Strategies for Obesity Management: Risk Stratification & Long-term Weight ControlAmerican Association of Clinical Endocrinologists (AACE), Dearborn, Michigan - 10/5/2013
Press Mentions
Nevro Announces American Association of Clinical Endocrinology Clinical Practice Guideline Has Been Updated to Include High-Frequency 10 kHz Spinal Cord Stimulation to Treat Painful Diabetic NeuropathyOctober 3rd, 2022- Nevro : Revolutionizing the Treatment of Painful Diabetic Neuropathy (PDN) with High Frequency (10 kHz) Spinal Cord StimulationJune 7th, 2022
- Panel Provides Update on the Future of Weekly, Oral, and Interchangeable InsulinsJune 6th, 2022
Grant Support
- Natural Insulin Receptor Tyrosine Kinase InhibitorNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
Committees
- member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2029
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
